The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michael F. Para

Ohio State University

Columbus

USA

[email]@osu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Ohio State University, Columbus, USA. 2010
  • Department of Medicine, Ohio State University, Columbus, USA. 2001
  • Ohio State University ACTU, University Hospitals Clinic, Columbus, OH 43210, USA. 2000
  • Division of Infectious Disease, The Ohio State University, Columbus, Ohio 43210, USA. 1999

References

  1. Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200. Para, M.F., Schouten, J., Rosenkranz, S.L., Yu, S., Weiner, D., Tebas, P., White, C.J., Reeds, D., Lertora, J., Patterson, K.B., Daar, E.S., Cavert, W., Brizz, B. J. Acquir. Immune Defic. Syndr. (2010) [Pubmed]
  2. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions. Para, M.F., Kalish, L.A., Collier, A.C., Pollard, R.B., Kumar, P.N., Mintz, L., Wallach, F.R., Drew, W.L. J. Acquir. Immune Defic. Syndr. (2001) [Pubmed]
  3. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion. Para, M.F., Kalish, L.A., Collier, A.C., Murphy, E.L., Drew, W.L. J. Infect. Dis. (2001) [Pubmed]
  4. Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333. Para, M.F., Glidden, D.V., Coombs, R.W., Collier, A.C., Condra, J.H., Craig, C., Bassett, R., Leavitt, R., Snyder, S., McAuliffe, V., Boucher, C. J. Infect. Dis. (2000) [Pubmed]
  5. ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team. Para, M.F., Meehan, P., Holden-Wiltse, J., Fischl, M., Morse, G., Shafer, R., Demeter, L.M., Wood, K., Nevin, T., Virani-Ketter, N., Freimuth, W.W. Antimicrob. Agents Chemother. (1999) [Pubmed]
 
WikiGenes - Universities